Proteoglycans contribution to association of Lp(a) and LDL with smooth muscle cell extracellular matrix

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 19, Issue 5, 1999, Pages 1162-1167

  Lundstam, Ulf ^a   Hurt Camejo, Eva ^a   Olsson, Gun ^a   Sartipy, Peter ^a   Camejo, Germán ^a,b   Wiklund, Olov ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b ASTRAZENECA R AND D   (Sweden)

Author keywords

Extracellular matrix; LDL; Lipoprotein(a); Smooth muscle cells

Indexed keywords

CHONDROITIN SULFATE; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; PROTEOGLYCAN;

ARTERY MUSCLE; ARTICLE; ATHEROGENESIS; BINDING SITE; EXTRACELLULAR MATRIX; FIBRINOLYSIS; FOAM CELL; HUMAN; HUMAN CELL; IONIC STRENGTH; LIPID BLOOD LEVEL; LIPOPROTEIN METABOLISM; MACROMOLECULE; PRIORITY JOURNAL; RECEPTOR AFFINITY; SMOOTH MUSCLE FIBER;

EID: 0032964724     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.19.5.1162     Document Type: Article

References (41)

1. Rosengren A, Wilhelmsen L, Eriksson E, Risberg B, Widel H. Lipoprotein(a) and coronary heart disease: A prospective case-control study in a population sample of middle aged men. BMJ. 1990;301:1248-1251.
2. Schaefer E, Lamon-Fava S, Jenner L, McNamara J, Ordovas J, Davis C, Abolafia J, Lippel K, Levy R. Lipoprotein(a) levels and risk for coronary artery disease in men: The lipid Research Clinics Primary Prevention Trial. JAMA. 1994;271:999-1003.
3. Howard G, Pizzo S. Lipoprotein(a) and its role in atherothrombotic disease. Lab Invest. 1993;69:373-386.
4. Lawn RM, Scanu AM. Lipoprotein(a). In. Fuster V, Ross R, Topol E, eds. Atherosclerosis and Coronary Artery Disease. Vol 1. Philadelphia, PA: Lippincott-Raven: 1996:151-161.
5. Rath M, Niendorf A, Reblin T, Dietel M, Krebber H, Beisiegel U. Detection and quantification of lipoprotein(a) in the arterial wall of 107 coronary bypass patients. Arteriosclerosis. 1989;9:579-592.
6. Williams KJ, Tabas I. The response-to-retention hypothesis of early atherogenesis. Arterioscler Thromb Vasc Biol. 1995;15:551-561.
7. Hurt-Camejo E, Olsson U, Wiklund O, Bondjers G, Camejo G. Cellular consequences of the association of apoB lipoproteins with proteoglycans: potential contribution to atherogenesis. Arterioscler Thromb Vasc Biol. 1997;17:1011-1017.
8. Nielsen L, Stender S, Jauhianien M, Nordestgaard B. Preferential influx and decreased fractional loss of lipoprotein(a) in atherosclerosis compared with non-lesioned rabbit aorta. J Clin Invest. 1996;98:563-571.
9. Wight TN. The Vascular Extracellular Matrix. In: Fuster V, Ross R, Topol E, eds. Atherosclerosis and Coronary Artery Disease. Vol 1. Philadelphia, PA: Lippincott-Raven; 1996:421-440.
10. Hughes S, Lou X-J, Ighani S, Grainger D, Lawn R, Rubin E. Lipoprotein(a) vascular accumulation in mice: in vivo analysis of the role of lysine binding sites using recombinant adenovirus. J Clin Invest. 1997; 100:1493-1500.
11. Boonmark N, X-J. L, Yang Z, Schwanz K, Zhang J-L, Rubin E. Modification of apolipoprotein(a) lysine binding site reduces atherosclerosis in transgenic mice. J Clin Invest. 1997;100:558-564.
12. Dahlén G, Ericson C, Berg K. In vitro studies of the interaction of isolated Lp(a) lipoprotein and other serum lipoproteins with glycosaminoglycans. Clin Genet. 1978;14:36-42.
13. Bihari-Varga M, Gruber E, Rotheneder M, Zechner R, Kostner G. Interaction of lipoprotein Lp(a) and low density lipoprotein with glycosaminoglycans from human aorta. Arteriosclerosis. 1988;8:851-857.
14. McLean J, Tomlinson J, Kuang W, Eaton D, Chen E, Fless G, Scanu A, Lawn R. Human apolipoprotein(a): cDNA sequence of an apolipoprotein homologous to plasminogen. Nature. 1987;330:132-137.
15. Jackson RL, Busch SJ, Cardin AD. Glycosaminoglycans: molecular properties, protein interactions and role in physiological processes. Physiol Rev. 1991;71:481-539.
16. Eisenberg S, Sehayek E, Olivecrona T, Vlodavsky I. Lipoprotein lipase enhances binding of lipoproteins to heparan sulfate on cell surfaces and extracellular matrix. J Clin Invest. 1992;90:2013-2021.
17. Tabas I, Yueqing L, Brocia R, Xu S, Swenson T. Lipoprotein lipase and sphingomyelinase synergistically enhance the association of atherogenic lipoproteins with smooth muscle cells and extracellular matrix. J Biol Chem. 1993;268:20419-20432.
18. Pillarisetti S, Obunike J, Berglund L, Goldberg I. Subendothelial retention of lipoprotein(a): Evidence that reduced heparan sulfate promotes lipoprotein binding to subendothelial matrix. J Clin Invest. 1997;100:867-874.
19. Trieu V, Zioncheck R, Lawn R, McConathy W. Interaction of apolipoprotein(a) with apolipoprotein B-containing lipoproteins. J Biol Chem. 1991; 266:5480-5485.
20. Trieu V, Mills E, Olsson U. Identification of apolipoprotein(a) binding site on apolipoprotein B. Biochem J. 1995;307:17-22.
21. Schwartz S. Smooth muscle migration in atherosclerosis and restenosis. J Clin Invest. 1997;99:2814-2817.
22. Hurt-Camejo E, Rosengren B, Camejo G, Sartipy P, Fager G, Bondjers G. Interferon gamma binds to extracellular matrix-chondroitin-sulfate proteoglycans, thus enhancing its cellular response. Arterioscler Thromb Vasc Biol. 1995;15:1456-1465.
23. Havel R, Eder H, Bragdon J. Distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest. 1955;34:1345-1353.
24. Laurell C-B. Electroimmunoassay. Scand J Clin Lab Invest. 1972;29: 1345-1353.
25. Koschinsky M, Tomlisson J, Zioncheck T, Schwartz K, Eaton D, Lawn R. Apoprotein(a). Expression and characterization of a recombinant form of the protein in mammalian cells. Biochemistry. 1991;30:5044-5051.
26. Albers JJ, Marcovina SM, Lodge MS. The unique lipoprotein(a): properties and immunochemical measurements. Clin Chem. 1990;36: 591-597.
27. Hurt-Camejo E, Camejo G, Rosengren B, Lopez F, C. A, Fager G, Bondjers G. Effect of arterial proteoglycans and glycosaminoglycans on low density lipoprotein oxidation and its uptake by human macrophages and arterial smooth muscle cells. Arterioscler Thromb. 1992;12:569-583.
28. 2 type II binds to extracellular matrix byglycan: modulation of its activity on low density lipoproteins by colocalization in glycosaminoglycan matrices. Arterioscler Thromb Vasc Biol. 1998;18:1934-1941.
29. Moscatelli D. Basic fibroblasts growth factor (bFGF) dissociates rapidly from heparan sulfates but slowly from receptors. J Biol Chem. 1992;267: 25803-25809.
30. Olsson U, Camejo G, Hurt-Camejo E, Elfsber K, Wiklund O, Bondjers G. Possible functional interactions of apolipoprotein B-100 segments that associate with cell proteoglycans and the apoB/E receptor. Arterioscler Thromb Vasc Biol. 1997;17:149-155.
31. Camejo G, Fager G, Rosengren B, Camejo-Hurt E, Bondjers G. Binding of low density lipoproteins by proteoglycans synthesized by proliferating and quiescent human arterial smooth muscle cells. J Biol Chem. 1993; 268:14131-14137.
32. Motulsky H. Intuitive Statistics. Oxford, England: Oxford University Press; 1994.
33. Pepin J, O'Neil J, Hoff H. Quantification of apo(a) and apoB in human atherosclerotic lesions. J Lipid Res. 1991;32:317-326.
34. Tailleux A, Torpier G, Caron B, Fruchart J-C, Fievet C. Immunological properties of apoB-containing lipoprotein particles in human atherosclerotic arteries. J Lipid Res. 1993;34:719-728.
35. Cardoso LE, Mourao PA. Glycosaminoglycan fractions from human arteries presenting diverse susceptibilities to atherosclerosis have different binding affinities to plasma LDL. Arterioscler Thromb. 1994;14: 115-124.
36. Edwards IJ, Xu H, Obunike J, Goldberg I, Wagner WD. Differentiated macrophages synthesize a heparan sulfate proteoglycan and a oversulfated chondroitin sulfate proteoglycan that bind lipoprotein lipase. Arterioscler Thromb Vasc Biol. 1995;15:400-409.
37. Labat-Robert J, Gruber E, Bihari-Varga M. Interaction between fibronectin, proteoglycans and lipoproteins. Int J Biol Macromol. 1990; 12:50-54.
38. van der Hoek Y, Sangrar W, Cote G, Kastelein J, Koschinsky M. Binding of recombinant apolipoprotein (a) to extracellular matrix proteins. Arterioscler Thromb. 1994;14:1792-1798.
39. Yashiro A, J. ON, Hoff H. Insoluble complex formation of lipoprotcin(a) with low density lipoprotein in the presence of calcium ions. J Biol Chem. 1993;268:4709-4715.
40. Vijayagopal P, Srinivasan SR, Radhakrishnamurthy B, Berenson GS. Lipoprotein-proteoglycan complexes from atherosclerotic lesions promote cholesteryl ester accumulation in human monocytes/macrophages. Arterioscler Thromb. 1992;12:237-249.
41. Maher V, Brown G. Lipoprotein(a) and coronary heart disease. Curr Opin Lipidol. 1995;6:229-235.